36 studies found for:    Open Studies | "intraocular melanoma"
Show Display Options
Rank Status Study
21 Recruiting Trial of AEB071 in Combination With BYL719 in Patients With Melanoma
Condition: Uveal Melanoma
Interventions: Drug: AEB071;   Drug: BYL719
22 Recruiting INCB024360 and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
Conditions: Mucosal Melanoma;   Recurrent Melanoma;   Recurrent Uveal Melanoma;   Stage IIIA Skin Melanoma;   Stage IIIA Uveal Melanoma;   Stage IIIB Skin Melanoma;   Stage IIIB Uveal Melanoma;   Stage IIIC Skin Melanoma;   Stage IIIC Uveal Melanoma;   Stage IV Skin Melanoma;   Stage IV Uveal Melanoma
Interventions: Drug: IDO1 Inhibitor INCB024360;   Biological: MELITAC 12.1 Peptide Vaccine;   Other: Laboratory Biomarker Analysis
23 Recruiting Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Conditions: Recurrent Uveal Melanoma;   Stage IIIA Uveal Melanoma;   Stage IIIB Uveal Melanoma;   Stage IIIC Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Drug: Cabozantinib S-malate;   Drug: Dacarbazine;   Other: Laboratory Biomarker Analysis;   Drug: Temozolomide
24 Recruiting Clinical and Histopathologic Characteristics of BAP1 Mutations
Conditions: Malignant Pleural Mesothelioma (MPM);   Choroidal Nevus;   Primary Uveal Melanoma (UM);   Metastatic Uveal Melanoma (UM);   Renal Cell Carcinoma;   Cholangiocarcinoma
Intervention: Other: tumor specimens
25 Unknown  Treatment Of Radiation Retinopathy Trial
Condition: Uveal Melanoma
Interventions: Drug: ranibizumab;   Drug: triamcinolone acetonide;   Other: sham
26 Recruiting Vascular Response to Brachytherapy Using Functional OCT
Condition: Uveal Melanoma
27 Recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma
Conditions: Metastatic Ocular Melanoma;   Metastatic Uveal Melanoma
Interventions: Drug: Aldesleukin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Young TIL
28 Recruiting TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy
Conditions: Exudative Retinal Detachment;   Uveal Melanoma
Interventions: Drug: Triamcinolone Acetonide;   Procedure: Transpupillary thermotherapy
29 Unknown  Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
Conditions: Ocular Melanoma;   Choroidal Melanoma;   Uveal Melanoma
30 Recruiting Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Conditions: Pleural Mesothelioma Malignant Advanced;   Peritoneal Mesothelioma Malignant Advanced;   Non-squamous Non-small Cell Lung Carcinoma Stage IIIB/IV (NSCLC);   Metastatic Uveal Melanoma;   Hepatocellular Carcinoma (HCC);   Glioma
Intervention: Drug: ADI-PEG 20
31 Recruiting Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma
Condition: Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors
Intervention: Drug: ADI-PEG 20
32 Unknown  Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
Conditions: Melanoma;   Radiotherapy;   Metastatic Disease
Intervention: Procedure: Treatment of metastatic disease
33 Recruiting The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases
Conditions: Melanoma;   Uveal Neoplasms
Intervention: Procedure: IHP
34 Unknown  Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Condition: Ocular Melanoma
35 Recruiting Cytogenetic Study of Ocular Melanoma
Condition: Choroidal Melanoma
36 Recruiting Definity for Ultrasound of Intraocular Tumors
Condition: Ocular Melanoma
Intervention: Device: Microbubble contrast agent

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years